250 related articles for article (PubMed ID: 26329973)
1. Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.
Kim S; Kim MY; Koh J; Go H; Lee DS; Jeon YK; Chung DH
Eur J Cancer; 2015 Nov; 51(17):2698-707. PubMed ID: 26329973
[TBL] [Abstract][Full Text] [Related]
2. Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions.
Teng F; Meng X; Wang X; Yuan J; Liu S; Mu D; Zhu H; Kong L; Yu J
Oncotarget; 2016 Sep; 7(39):64318-64329. PubMed ID: 27602763
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC).
Jiang L; Su X; Zhang T; Yin X; Zhang M; Fu H; Han H; Sun Y; Dong L; Qian J; Xu Y; Fu X; Gavine PR; Zhou Y; Tian K; Huang J; Shen D; Jiang H; Yao Y; Han B; Gu Y
Oncotarget; 2017 Apr; 8(16):26845-26857. PubMed ID: 28460468
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy.
Chen J; Zhong W; Yang M; Hou W; Wang X; Xia K; Yu H; Yang M; Zhou B; Wang B; Huang J; Lin T
Cancer Immunol Immunother; 2021 Sep; 70(9):2657-2668. PubMed ID: 33606065
[TBL] [Abstract][Full Text] [Related]
5. Correlation between PD-L1 expression of the tumour cells and lymphocytes infiltration in the invasive front of urothelial carcinoma.
Chen X; Chen H; Lin R; Li Y; Guo Y; Chen Q; Zhang Y; Cai G; Hu M; Chen G
J Clin Pathol; 2023 Dec; 77(1):61-67. PubMed ID: 36319076
[TBL] [Abstract][Full Text] [Related]
6. Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer.
Lopez de Rodas M; Nagineni V; Ravi A; Datar IJ; Mino-Kenudson M; Corredor G; Barrera C; Behlman L; Rimm DL; Herbst RS; Madabhushi A; Riess JW; Velcheti V; Hellmann MD; Gainor J; Schalper KA
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35649657
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and prognostic impact of tumor-infiltrating lymphocytes in uterine carcinosarcoma.
da Silva JL; de Albuquerque LZ; Rodrigues FR; de Mesquita GG; Chaves CBP; Bonamino MH; de Melo AC
BMC Cancer; 2021 Dec; 21(1):1306. PubMed ID: 34876047
[TBL] [Abstract][Full Text] [Related]
8. Desmoplasia in non-small cell lung carcinomas is associated with low programmed death-ligand 1 expression and the absence of tumor-infiltrating lymphocytes.
Tancoš V; Plank L; Farkašová A; Grendár M; Mazuráková A; Huťka Z; Kviatkovská Z
Neoplasma; 2023 Oct; 70(5):697-705. PubMed ID: 38053375
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 and PD-L2 Expression Levels Are Low in Primary and Secondary Adenoid Cystic Carcinomas of the Orbit: Therapeutic Implications.
Wolkow N; Jakobiec FA; Afrogheh AH; Kidd M; Eagle RC; Pai SI; Faquin WC
Ophthalmic Plast Reconstr Surg; 2020; 36(5):444-450. PubMed ID: 31990894
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas.
Samman DME; Mahdy MME; Cousha HS; Kamar ZAER; Mohamed KAK; Gabal HHA
J Pathol Transl Med; 2021 Nov; 55(6):388-397. PubMed ID: 34638219
[TBL] [Abstract][Full Text] [Related]
11. TIM-3 expression induces resistance to PD-1 inhibitor in G-CSF-producing lung spindle cell carcinoma: A case report.
Hayashi F; Akagi K; Taniguchi H; Matsutake T; Kawahara H; Sekine I; Gyotoku H; Takemoto S; Soda H; Ashizawa K; Mukae H
Thorac Cancer; 2023 Dec; 14(36):3556-3560. PubMed ID: 37926435
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours.
Lamarca A; Nonaka D; Breitwieser W; Ashton G; Barriuso J; McNamara MG; Moghadam S; Rogan J; Mansoor W; Hubner RA; Clark C; Chakrabarty B; Valle JW
Oncotarget; 2018 Mar; 9(19):14922-14938. PubMed ID: 29599916
[TBL] [Abstract][Full Text] [Related]
13. Genomic Landscape of Pulmonary Sarcomatoid Carcinoma.
Kwon HJ; Lee S; Han YB; Lee J; Kwon S; Kim H; Chung JH
Cancer Res Treat; 2024 Apr; 56(2):442-454. PubMed ID: 37973906
[TBL] [Abstract][Full Text] [Related]
14. PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread.
Vesterinen T; Kuopio T; Ahtiainen M; Knuuttila A; Mustonen H; Salmenkivi K; Arola J; Haglund C
Endocr Connect; 2019 Aug; 8(8):1168-1175. PubMed ID: 31299636
[TBL] [Abstract][Full Text] [Related]
15. Common clinicopathological and immunological features of sarcomatoid carcinoma across organs: A histomorphology-based cross-organ study.
Morisue R; Kojima M; Suzuki T; Watanabe R; Sakamoto N; Sakashita S; Harada K; Nakai T; Ishii G; Nakatsura T; Gotohda N; Ishikawa S
Int J Cancer; 2023 Dec; 153(12):1997-2010. PubMed ID: 37548077
[TBL] [Abstract][Full Text] [Related]
16. HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape.
Perea F; Sánchez-Palencia A; Gómez-Morales M; Bernal M; Concha Á; García MM; González-Ramírez AR; Kerick M; Martin J; Garrido F; Ruiz-Cabello F; Aptsiauri N
Oncotarget; 2018 Jan; 9(3):4120-4133. PubMed ID: 29423109
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of PD-1 and its ligands in non-small cell lung cancer.
Usluer O; Gökbayrak ÖE; Erol A; Aktaş TÇ; Batıhan G; Örs Kaya Ş; Üçvet A; Aydoğdu Z; Altun Z; Öztop İ; Aktaş S
Turk Gogus Kalp Damar Cerrahisi Derg; 2024 Jan; 32(1):84-92. PubMed ID: 38545362
[TBL] [Abstract][Full Text] [Related]
18. Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imaging.
Mierzwicka JM; Petroková H; Kafková LR; Kosztyu P; Černý J; Kuchař M; Petřík M; Bendová K; Krasulová K; Groza Y; Vaňková L; Bharadwaj S; Panova N; Křupka M; Škarda J; Raška M; Malý P
J Transl Med; 2024 May; 22(1):426. PubMed ID: 38711085
[TBL] [Abstract][Full Text] [Related]
19. Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8
Ji Y; Heng Y; Zhu X; Zhang D; Tang D; Zhou J; Lin H; Ma J; Ding X; Tao L; Lu L
Transl Oncol; 2024 Apr; 45():101936. PubMed ID: 38678970
[TBL] [Abstract][Full Text] [Related]
20. The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility.
Sakran MI; Alalawy AI; Alharbi AA; El-Hefnawy ME; Alzahrani SM; Alfuraydi A; Alzuaibr FM; Zidan NS; Elsaid AM; Toraih EA; Elshazli RM
Int Immunopharmacol; 2023 Dec; 125(Pt A):111180. PubMed ID: 37939515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
